Abstract-Goal: Quantitative assessment of hepatic insulin extraction (HE) after an oral glucose challenge, e.g., a meal, is important to understand the regulation of carbohydrate metabolism. The aim of the current study is to develop a model of system for estimating HE. Methods: Nine different models, of increasing complexity, were tested on data of 204 normal subjects, who underwent a mixed meal tolerance test, with frequent measurement of plasma glucose, insulin, and C-peptide concentrations. All these models included a two-compartment model of C-peptide kinetics, an insulin secretion model, a compartmental model of insulin kinetics (with number of compartments ranging from one to three), and different HE descriptions, depending on plasma glucose and insulin. Model performances were compared on the basis of data fit, precision of parameter estimates, and parsimony criteria.
I. INTRODUCTION

P
ERIPHERAL insulin concentrations reflect the net effect of insulin secretion and hepatic extraction of portal insulin [1] . While C-peptide and insulin are secreted into the portal vein in equimolar concentrations, fasting insulin and C-peptide concentrations do not preserve equimolarity since the liver extracts insulin but not C-peptide. Estimating hepatic extraction of insulin (HE) becomes more complex in physiological situations, such as after meal ingestion, since in these circumstances insulin and C-peptide concentrations vary with a time course reflecting both the differences in their kinetics as well as HE [2] , [3] .
Prior studies have suggested that HE removes approximately 50%-80% of the insulin appearing in the portal circulation. This process appears to be dynamic and is affected by the amplitude of portal insulin pulses [4] , circulating free fatty acids [5] , and hyperglycemia [6] . Therefore, measuring HE in dynamic situations is important, but direct measurement is invasive, requiring the insertion of catheters into the portal and hepatic veins, respectively. Estimation of HE using mathematical models is a reasonable alternative. Models utilize the fact that C-peptide and insulin are secreted in equimolar concentrations from the beta-cells and that the liver extracts insulin, but not C-peptide. A recent model formulated to assess HE was proposed by Toffolo et al. [7] , which uses plasma glucose, insulin, and C-peptide measured during an insulinmodified intravenous glucose tolerance test (IM-IVGTT). The model estimates the insulin secretion rate (ISR) and the insulin delivery rate (IDR) from C-peptide and insulin concentrations, respectively. Using these two variables, it is possible to obtain an estimate of the HE profile, as (ISR-IDR)/ISR. Of note, in this case, the functional description adopted for IDR is similar to that used for describing ISR, i.e., that IDR is made up of two components: the first phase is proportional to the rapid rise in glucose concentration, and the second phase is proportional to delayed rise in plasma glucose concentration. In addition, since the concurrent estimation of secretion and kinetics during a single experiment in a given individual is difficult [8] , the C-peptide kinetic parameters are usually fixed to standard population values obtained from individual anthropometric characteristics [9] . Conversely, insulin kinetic parameters can be estimated from an IM-IVGTT, since the short insulin infusion administered 20-25 min after the glucose bolus allows the individual assessment of insulin kinetics.
Campioni et al. [3] directly described HE during a standard mixed meal as a piecewise linear function. In this model, insulin kinetics is fixed to a population model derived from data of 204 healthy subjects who underwent an IM-IVGTT [10] . The main limitation of this method arises from how HE is described: a piecewise linear function with a given number of breakpoints, i.e., a model of data, which does not explore the mechanistic relationship between involved variables and does not provide physiologically based parameters [11] , [12] . Moreover, this expression makes the model vulnerable to noise, since the HE profile may rapidly vary to fit fluctuations in peripheral insulin concentrations.
The aim of this study was to propose a new physiological model of system of insulin kinetics, i.e., a model aiming to mechanistically describe the system behavior [11] , [12] . The model is selected among nine models with different number of compartments and different mechanistic descriptions on how HE depends on plasma glucose and insulin concentrations. These models are tested against data of a frequently sampled mixed 0018-9294 © 2015 IEEE. Personal use is permitted, but republication/redistribution requires IEEE permission.
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meal (21 plasma samples), in 204 healthy subjects [10] (the same dataset used in [3] ). Using these models, it is possible to obtain also an index of HE sensitivity, in addition to total and basal indices of HE. After selecting the most parsimonious model, we tested its ability to describe the data during a standard 11 sample meal tolerance test (MTT) [13] .
II. METHODS
A. Subjects and Experimental Protocol
We used data from a previous study [10] in which 204 nondiabetic subjects [117 males and 87 females, age 55.5 ± 1.5 year (mean ± SE), body mass index 26.6 ± 0.2 kg/m 2 , body surface area 1.90 ± 0.01 m 2 ] underwent a mixed meal (10 kcal/kg body weight, 45% carbohydrate, 15% protein, 40% fat) consumed over a 15-min period. 
B. C-Peptide Kinetics Model
A two-compartment model is used to describe C-peptide kinetics, as initially proposed by Eaton et al. [14] (see Fig. 2 )
where CP 1 and CP 2 (pmol/L) are C-peptide concentrations in the accessible and in the peripheral compartment, CP b (pmol/L) is the basal plasma C-peptide concentration, ISR (pmol/min) is the beta-cell insulin (and C-peptide) secretion rate, V c (L) is the C-peptide distribution volume in compartment 1, and k 21 , k 12 , k 01 (min −1 ) are transfer rate parameters, fixed to standard population values, by using Van Cauter et al. formulas [9] .
C. C-Peptide Secretion Model
The model of C-peptide secretion [13] (see Fig. 2 ) describes the three components of pancreatic secretion: basal (ISR b ), static (ISR s ), proportional to delayed glucose concentration, and dynamic (ISR d ), proportional to glucose rate of increase (see Fig. 2 )
ISR b can be obtained from the steady-state constraint of (1): ISR s represents the provision of releasable insulin controlled by glucose concentration G (mmol/L) in a linear dynamic fashion: in other words, if plasma glucose shows a step increase above a threshold level h (mmol/L), the provision tends, with a rate constant α (min −1 ), and thus with a delay T = 1/α (min), toward a steady-state value that is linearly dependent to the glucose step through a parameter Φ s (10
ISR d is the secretion of insulin from the promptly releasable pool, and it is proportional to the rate of increase of glucose
D. Insulin Kinetics and Hepatic Extraction Models
Hepatic extraction during an MTT has been described by Campioni et al. as a piecewise linear function [3] . This model allows the reconstruction of HE profile from plasma C-peptide, insulin, and glucose concentrations and provides an index of total hepatic extraction, without assuming any mechanistic description of the phenomena controlling HE. Hepatic insulin extraction decreases when glucose and insulin concentrations rise (see [3, Fig. 4] ). Therefore, it is reasonable to assume an inverse relation between HE and plasma glucose and/or insulin concentration.
Here, we compare nine different models of system by examining a single, two-, and three-compartment description of insulin kinetics (see Fig. 3 ), with different HE functional relationships.
Model I: Insulin kinetics is modeled by a single compartment (see Fig. 3 , panel a) [3] :
where n (min −1 ) is the rate constant of nonhepatic insulin clearance, IDR (pmol/min) is the posthepatic insulin delivery rate, V I (L) is the insulin volume of distribution, I (pmol/L) is plasma insulin concentration, and I b (pmol/L) is its basal value. The parameters V I and n were here fixed to the values obtained from the linear regression models proposed by Campioni et al. [3] .
HE is assumed to be linearly dependent on plasma glucose concentration G (mmol/L)
where a G (L/mmol) is a parameter representing the control of plasma glucose on HE, and a 0G (dimensionless) is obtained from the steady-state constraint
HE b and HE tot indices can be calculated as in [3] 
(10)
An index of HE sensitivity to glucose, S HE G (L/mmol), can also be derived from these model parameters: Model II. Also, this model has a single compartment insulin kinetics (see Fig. 3 , panel b), [see (7)], but HE is assumed to be dependent on plasma insulin concentration I (pmol/L)
where a I (L/pmol) is a parameter representing the control of insulin on HE, and a 0I (dimensionless) is obtained from the steady-state constraint
HE b and HE tot were calculated using (10) and (11) . In this case, an index accounting for HE sensitivity to insulin S HE I can be derived
Model III. This model again describes insulin kinetics with a single compartment [see (7); Fig. 3, panel c] , but HE is dependent on both plasma insulin and glucose concentrations
(16) where a 0G I (dimensionless) is easily obtained from:
and 
where a 0GI (dimensionless) is easily obtained from the steadystate constraint
HE b and HE tot are derived as described above, while S HE G and S HE I can be calculated as:
Model V. Here, a two-compartment model (see Fig. 3 , panel d) is used to describe insulin kinetics, similarly to what reported in [15] 
where I L , I P are insulin concentrations in liver and plasma, respectively, (pmol/L); I (pmol/L) is plasma insulin concentration; ISR (pmol/min) is insulin secretion rate; BW is individual body weight (kg); V P is distribution volume of insulin (L/kg), to be estimated; m 1 , m 4 , (min −1 ) are rate parameters to be estimated; m 2 (min −1 ) is rate parameter that is fixed to 0.268 min
because of the hepatic plasma flow observed in normal subjects [16] ; and m 3 (min −1 ) is a time-varying parameter which, according to Dalla Man et al. [17] , is:
In the basal state, one has
where
For HE, we used (8) and (9), i.e., the model assumes that HE is controlled by plasma glucose.
Similarly, it is possible to obtain a basal and a total index of HE
For S HE G , the same expression of (12) holds. Model VI. This model (see Fig. 3 , panel e) describes insulin kinetics using the same two-compartment structure shown above [see (22) - (30)]. The only difference consists of the HE functional description, which just accounts for insulin concentration [see (13) and (14)]. For the calculation of HE b , HE tot , and S HE I , (29), (30), and (15), respectively, are used.
Model VII. A three-compartment-model (see Fig. 3 , panel f) describes insulin kinetics across the liver, plasma, and extravascular space [16] :
where, compared to Model VI, I EV (pmol/L), i.e. insulin in the extravascular compartment, and the parameters m 5 and m 6 (min −1 ), have been added.
For I EV , in basal state, one has
Equations (25)- (28) from Model V are still valid, but for HE, a dependence on glucose concentration is used, as shown in (8) .
For the calculation of HE b , HE tot , and S HE G , (29), (30), and (12), respectively, are used.
Model VIII. Here, insulin kinetics is described using the same three-compartment description (see Fig. 3, panel g ) shown above [see (31)-(34)], but HE accounts for insulin concentration only [see (13) and (14) (20) , and (21), respectively, are used.
E. Model Identification
C-peptide and insulin models were identified in all subjects simultaneously, as in [7] , by nonlinear weighted least squares, here implemented in MATLAB (R2012). In particular, ISR parameters were estimated from C-peptide minimal model, by fixing C-peptide kinetic parameters according to standard population values [9] , while insulin kinetic and hepatic insulin extraction parameters were estimated by identifying the models. Error on C-peptide and insulin measurements was assumed to be independent, Gaussian, with zero mean, and variance dependent on the C-peptide and insulin measurements, respectively, as reported in [7] . Glucose is the model forcing function, thus it is assumed to be known without error.
Data are presented as mean ± SD. Two samples paired and unpaired comparisons were undertaken using nonparametric and T-test, according to the gaussianity, which was verified with the Lilliefors test.
F. Model Selection
The best model is selected by comparing model performances on the basis of different criteria: residual independence (Anderson Run Test), precision of parameters estimates (expressed as percent coefficient of variation, CV%), ability to describe the data (weighted residual square sum, WRSS), and model parsimony (Akaike Information Criterion, AIC), here calculated as follows:
where P is the number of model parameters.
III. RESULTS
A. Model Selection
Results are summarized in Table I , for both the C-peptide and insulin models. Briefly, Models V and VI have been rejected because randomness of insulin weighted residuals is poor, and the estimated parameters, especially those of the C-peptide model, exhibit a poor precision.
Models III and VIII were also rejected because parameters were estimated with poor precision.
For what concerns the remaining models (Models I, II, IV, VII, and IX), they all provide a good precision of parameter estimates, but AIC shows that Model VII is the most parsimonious (AIC C−peptide = 156 ± 100 and AIC Insulin = 136 ± 57, with p<0.05 if compared to the other ones).
Time courses of weighted residuals, obtained with Model VII, are reported in Fig. 4 (C-peptide and insulin, top and bottom panel, respectively). The apparent over-and underestimates of C-peptide and insulin data in the first 30 min (see Fig. 4 ) is due to a small percentage of subjects who did not pass the Run Test (see Table I ). Parameter estimates are shown in Table II , left column.
B. FS-MTT Versus SS-MTT
The model performed well also with a reduced sampling scheme, i.e., the SS-MTT [13] . The parameter estimates using the SS-MTT are shown in Table II , right column.
The comparison between the model performance during FSand SS-MTT is shown in Table III. In the SS-MTT, weighted residuals are substantially random in all the subjects, and WRSS, normalized with the number of samples, are comparable with those obtained with the FS-MTT. Moreover, the precision of parameter estimates is still good, despite loss of ten samples.
IV. DISCUSSION
The amount of insulin reaching the systemic circulation is not only dependent on the amount secreted by pancreatic beta-cells, but also on the insulin percentage that is extracted by the liver from the portal circulation, during the first-pass transit. HE usually approximates 50%, even if it varies depending on different conditions; since it contributes to cellular control on insulin, it is related to insulin action, and thus, it needs to be properly quantified, in basal, as well as in dynamic situations (e.g., after an oral glucose load). Since direct measurement of HE is very invasive, the current method used to assess HE employs mathematical models that utilize the measurements of plasma glucose, insulin, and C-peptide concentrations to be applied. At the base of these models, there is the known concept that C-peptide and insulin are equimolarly secreted, but only insulin is extracted by the liver; this fact allows the conception of models which describe insulin, and thus C-peptide, secretion, and kinetics, including HE.
The current state of the art for estimating HE, during a meal test, is represented by the model previously described by Campioni et al. [3] . ISR was obtained from the two-compartment oral C-peptide model [13] , [14] , while HE was described as a piecewise linear function with seven breakpoints, in which the values of HE were parameters to be estimated by fitting the model to insulin data. This fact enabled the model to describe meal data. On the other hand, the limitation of this approach arises from the description of HE, which lacks a physiological or mechanistic meaning, and makes the model vulnerable to noise.
In order to improve the HE assessment, we thought to introduce a new physiological description of HE based on the evidence that during an oral test, while glucose and insulin concentrations rise, the HE profile decreases. This relationship is derived from the reconstructed profiles of HE [3] , and accounts for the observation that nutrient intake modifies HE [18] , [19] , and that glucose ingestion both stimulates insulin secretion and reduces HE [6] . Moreover, Pivovarova et al. [20] have demonstrated that insulin degrading enzyme activity, which is the main enzyme responsible for cellular insulin degradation, is inhibited by hyperglycemia and hyperinsulinemia. For all these reasons, we described HE as a linear function of plasma glucose and insulin alone, and then in combination; all these expressions were introduced first in the single- [3] , then in the two- [15] , [17] (just glucose and insulin alone), and three-compartment (glucose and insulin alone, as well as in combination) [16] insulin models, generating nine new models, that were compared. In all these models, C-peptide and insulin data were identified simultaneously, as in [7] .
It is notable that, although in the single-compartment version the dependence of HE on insulin or glucose alone had similar performances (see Table I ), the increase in model order makes the relationship between HE and insulin unable to provide reliable results (see Table I ). Moreover, a linear dependence of HE on both insulin and glucose concentrations is only provided in the single-compartment description (Model III), while the bilinear dependence was tested both in the single-(Model IV), and in the three-compartment description (Model IX). This was done to test that the poor performance of Model IV (in comparison with the selected model) was due to the single compartment structure instead of the bilinear control. In fact, since glucose and insulin profiles are correlated during the meal, these controls on HE did not lead to a satisfactory parameter estimates precision (Model III), or to a substantially improved model performance (Models IV and IX).
Based on our results, Model VII, which describes insulin kinetics using three compartments [16] , and contains an expression of HE dependence on glucose concentration, was chosen.
The new model shows good performance in terms of precision of parameter estimates and its ability to describe insulin data. Concerning C-peptide weighted residuals, though Fig. 4 , top panel, does not show a random distribution, on average, this is mainly due to a small percentage of the subjects, as confirmed by the Run Test. In addition, it is to note that this tendency to underestimate C-peptide concentration also occurs with the model of data [3] (not shown); this is partially a result of the estimation of the parameter h [see (5) ], which tends to favor insulin data fit more than C-peptide one and to the necessity to fix C-peptide kinetics to population values. However, Model VII remains superior than the other tested models and the model of data [3] , also in the ability to fit C-peptide data, providing lower WRSS and AIC indices (WRSS Model of data = 231 ± 299 versus WRSS Model VII = 148 ± 100; AIC Model of data = 239 ± 299 versus AIC Model VII = 156 ± 100). If compared to the Campioni et al. model [3] , which contains a piecewise linear description for HE, the resulting HE patterns are different. The average HE obtained from Model VII is shown in Fig. 5 , together with that provided by Campioni et al. [3] . Evidently, HE decreases more rapidly and to a greater extent with Model VII, than with the model of data; in addition, the new profile returns to its basal state at the end of the experiment, as would be expected 420 min after meal ingestion. Although both HE b and HE tot indices provided by Campioni et al. differ significantly from those reported by the new model (p<0.05) and they are negatively correlated (R = −0.034 and p>0.05, R = −0.0117 and p>0.05, for basal and total indices, respectively), it is of note that, like previous reports, both demonstrate a high percentage of insulin extraction (%) = 66%]; this is due to the fact that, in Model VII, HE b also depends on m 4 , that is one of the estimated parameters, while in [3] , the same index is calculated from population values and basal measurements. However, the differences in absolute values likely reflect the differences in model structure adopted to calculate HE.
An interesting model insight is found by dividing the entire database into two groups according to age, as done in [10] The new model is potentially applicable to a variety of clinical studies, where both C-peptide and insulin concentrations are measured, e.g., in hypertension [21] , [22] , prediabetes, and type 2 diabetes [23] , [24] .
The new model offers many advantages. The use of a three-compartment description for insulin kinetics is more physiological than the single-and two-compartment models, since it considers plasma, liver, and extravascular spaces. Furthermore, differently from the piecewise linear function, being HE linearly dependent on glucose concentration, a new index of HE sensitivity to glucose is available, which may be useful in various pathophysiological studies. This index measures the response of the effect of glucose concentration on the suppression of HE. Thus, together with insulin sensitivity and beta-cell responsivity to glucose, it may highlight specific defects in the mechanisms controlling glucose homeostasis. In other words, a subject may be hyperglycemic for several reasons, e.g., low insulin sensitivity, low beta-cell responsivity to glucose or because the insulin extraction is too high, despite the high glucose concentration would require more insulin entering the circulation. Quantifying the ability of the liver to suppress HE in relation to prevailing glucose concentration is important to better understand glucose regulation and its failure in pathological states.
Finally, another advantage of the new model, is that, besides showing good performances in the FS-MTT condition [10] , it can also describe the data using the SS-MTT time grid [13] , providing precise parameter estimates (see Table III ), and well correlated HE indexes, among the two tests. In this regard, one limitation of this study is that we did not test the performance of the other models with SS-MTT. However, Models VIII and IX, having the same number of parameters of Model VII, are likely expected to perform worse than Model VII even with the SS-MTT. Lower order models may in principle relatively improve their performances with a reduced sampling schedule. However, Models III, V, and VI already show bad precision of the estimates with the FS-MTT. This is not the case for Models I, II, and IV (all based on the single compartment model of insulin kinetics). However, since it has been established that a three compartment model is needed to well describe insulin kinetics, the use of a single compartment can introduce some bias and undesired compensations among model parameters.
V. CONCLUSION
The present study demonstrates that the HE model proposed by Campioni et al. can be improved by adopting a three compartment model for the description of insulin kinetics, and by substituting the piecewise linear function with a simple linear expression which links HE to plasma glucose concentration. Future developments could concern the introduction of this new model in the meal simulation model of the glucose and insulin system [17] , replacing the pre-existent two-compartment insulin kinetics, and the linear relationship that links HE to insulin secretion, which suffers from some limitations in the prediction of HE in a given individual. Further studies will be required to assess the validity of this model during different oral stimuli, e.g., OGTT, and to evaluate its ability to discriminate between subjects with differing glucose tolerance status and β-cell function.
